Pharmacodynamics of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model of Infection

The pharmacodynamics of gemifloxacin against Streptococcus pneumoniae were investigated in a dilutional pharmacodynamic model of infection. Dose fractionation was used to simulate concentrations of gemifloxacin in human serum associated with 640 mg every 48 h (one dose), 320 mg every 24 h (two doses...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	MacGowan, Alasdair P., Rogers, Chris A., Holt, H. Alan, Wootton, Mandy, Bowker, Karen E.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90752/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11557490/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.10.2916-2921.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!